The last few years have seen a clear up-tick in initiatives to strengthen governmental oversight of foreign direct investment (FDI). The U.S. has intensified the CFIUS regime, the EU has created a coordination and oversight regime for national FDI controls, and numerous other countries around the world are taking similar steps to protect vital strategic assets from foreign takeover.
The current COVID-19 crisis has brought these efforts into sharper focus – with new and strengthened initiatives to protect the ‘sovereignty’ of the healthcare sector and related R&D assets and calls to protect strategic sectors from “predatory” acquisitions by foreign investors.
A transatlantic team of Baker Botts lawyers will explore these developments in the U.S., EU and across the globe and discuss what they mean for transactions and FDI.
To view a recording of the webinar please click here.
ABOUT BAKER BOTTS L.L.P.
Baker Botts is an international law firm of approximately 725 lawyers practicing throughout a network of 13 offices around the globe. Based on our experience and knowledge of our clients' industries, we are recognized as a leading firm in the technology, energy, and life sciences sectors. Since 1840, we have provided creative and effective legal solutions for our clients while demonstrating an unrelenting commitment to excellence. For more information, please visit bakerbotts.com.